Application of simple lipid treatment goals in patients with atherosclerotic disease

Area of Science:

• Cardiovascular Medicine
• Lipid Metabolism
• Preventive Cardiology

Background:

• Established atherosclerotic disease requires effective lipid management.
• Current guidelines for lipid-lowering therapy vary in their targets.
• Specific lipid parameters like triglycerides and HDL-cholesterol are crucial in secondary prevention.

Purpose of the Study:

• To compare the efficacy of three lipid management guidelines: "5-4-3-2-1", "5-3", and "3-1.5".
• To evaluate the "3-1.5" criterion (LDL-C < 3.0 mmol/L and TG < 1.5 mmol/L) for secondary cardiovascular prevention.
• To assess the impact of these guidelines on achieving desirable levels of HDL-cholesterol and total to HDL-cholesterol ratio.

Main Methods:

• A multicentre observational study involving 2134 patients on lipid-lowering therapy.
• Monitoring patient adherence to the "5-4-3-2-1", "5-3", and "3-1.5" lipid management guidelines.
• Analysis of lipid profiles, including total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides.

Main Results:

• Only 19.2% met the "5-4-3-2-1" guideline, while 36.2% met the "5-3" guideline.
• The "3-1.5" criterion was fulfilled by 22.5% of patients.
• A good conformity was observed between the "5-4-3-2-1" and "3-1.5" criteria.
• Patients meeting the "5-3" guideline often had unfavorable HDL-C and TG levels (approx. 50%), whereas only 15% of those meeting "3-1.5" had HDL-C < or = 1.0 mmol/L.

Conclusions:

• The "3-1.5" treatment goal significantly increased the proportion of patients with desirable HDL-cholesterol and total to HDL-cholesterol ratio.
• This guideline is particularly beneficial for secondary prevention in diabetic patients.
• The "3-1.5" criterion is recommended for optimizing lipid management in high-risk cardiovascular patients.